Aclaris Therapeutics

Aclaris Therapeutics develops drugs for immuno-inflammatory conditions. 

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2015
Stage of Initial Investment
Series C
Initial Investment Year
2015
Aclaris Portco Hover Image